STRONG prehabilitation before elective ventral hernia repair: Learnings from recruitment challenges in a randomized controlled trial
6 affiliations
- 1WHO-CC, the Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark
- 2Center for Perioperative Optimization, Department of Surgery, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark
- 3Departement of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
- 4Department of Surgery, Holbæk Hospital, part of Copenhagen University Hospitals, Holbæk, Denmark
- 5Center for Surgical Science, Department of Surgery, Zealand University Hospital, Køge, Denmark
- 6Department of Health Sciences, Faculty of Medicine, Lund University, Lund, Sweden
Abstract
Background: The impact of smoking, nutrition, alcohol, and physical inactivity (SNAP) on the outcome of ventral hernia repair remains underexplored. This trial aimed to evaluate the effect of targeted, intensive lifestyle prehabilitation on postoperative complications. Methods: The STRONG-Hernia trial (NCT06611462) was a multicenter, parallel-group, centrally randomized controlled trial at two Danish university hospitals. Adults scheduled for elective ventral hernia repair with ≥1 risky SNAP factor were randomized (1:1) to STRONG prehabilitation or standard care. Prehabilitation comprised six weekly in-hospital sessions of education, motivational, and pharmaceutical support tailored to each patient’s SNAP factors. The primary outcome was postoperative complications ≤30 days. Secondary outcomes included lifestyle changes and health-related quality of life (EQ-5D). Final primary outcome assessment and statistical analyses were blinded. Power calculation required inclusion of 2 × 199 patients. Results: Between March 2024 to May 2025, 43 patients were randomized with 21 to STRONG prehabilitation and 22 to standard care. Around 75% had one risky lifestyle factor, and 25% had ≥ 2; obesity was most common. Shortly after randomization, two prehabilitation participants were excluded due to no surgery. At end-of-intervention, 13/19 in the prehabilitation group had optimized all risky lifestyles versus 0/22 in the control group (p < 0.01). Three additional participants in each group did not undergo surgery. At 30 days, complications occurred in 3/16 prehabilitation and 4/19 control participants (p = 1.00). EQ-5D VAS remained unchanged in the prehabilitation group from baseline but decreased significantly in the control group (p = 0.03). EQ-5D-5L index changes were similar between groups (p = 0.92). Challenges encountered included outsourcing of patients, insufficient recruitment strategy, and a low inclusion rate. Conclusion: The trial was terminated early due to slow recruitment and was therefore not powered to assess the effect of the prehabilitation intervention on postoperative complications. The findings suggest that the STRONG program seems promising for optimizing risky lifestyles, although these lifestyle results should be considered preliminary. Insights from this trial may help address recruitment challenges essential for completing a future adequately powered trial on postoperative complications.
Related
- Effects of myofascial release on clinical outcomes and muscle viscoelastic properties in patients with breast cancer: A randomized controlled trial
- Feasibility and acceptability of a randomized controlled trial of a patient-centred transition program for stroke survivors and their caregivers—P-NAVISTROKE study
- Machined versus cast abutments for dental implants: a 1-year within-patient multicentre randomized controlled trial assessing marginal seal capacity and outcomes
- Evaluating the efficacy and safety of therapeutic plasma exchange in snakebite-associated thrombotic microangiopathy compared to standard care alone: study protocol for a multicenter randomized controlled trial
- Influence of a full-spectrum aqueous extract of black cardamom (Amomum subulatum Roxb.) fruits on focus/alertness and executive function: a randomized, double-blind, placebo-and active- controlled, 14-day comparative study in healthy working professionals
BibTeX
@article{jensen2026strong,
title = {{STRONG prehabilitation before elective ventral hernia repair: Learnings from recruitment challenges in a randomized controlled trial}},
author = {Sofie Anne-Marie Skovbo Jensen and Susanne Vahr Lauridsen and Siv Fonnes and Jacob Rosenberg and Birgitte Brandstrup and Frederik Helgstrand and Hanne Tønnesen},
journal = {PLOS One},
year = {2026},
month = oct,
doi = {10.1371/journal.pone.0360482},
url = {https://doi.org/10.1371/journal.pone.0360482},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - STRONG prehabilitation before elective ventral hernia repair: Learnings from recruitment challenges in a randomized controlled trial
AU - Sofie Anne-Marie Skovbo Jensen
AU - Susanne Vahr Lauridsen
AU - Siv Fonnes
AU - Jacob Rosenberg
AU - Birgitte Brandstrup
AU - Frederik Helgstrand
AU - Hanne Tønnesen
PY - 2026
DA - 2026/10/27
JO - PLOS One
DO - 10.1371/journal.pone.0360482
UR - https://doi.org/10.1371/journal.pone.0360482
AB - Background: The impact of smoking, nutrition, alcohol, and physical inactivity (SNAP) on the outcome of ventral hernia repair remains underexplored. This trial aimed to evaluate the effect of targeted, intensive lifestyle prehabilitation on postoperative complications. Methods: The STRONG-Hernia trial (NCT06611462) was a multicenter, parallel-group, centrally randomized controlled trial at two Danish university hospitals. Adults scheduled for elective ventral hernia repair with ≥1 risky SNAP factor were randomized (1:1) to STRONG prehabilitation or standard care. Prehabilitation comprised six weekly in-hospital sessions of education, motivational, and pharmaceutical support tailored to each patient’s SNAP factors. The primary outcome was postoperative complications ≤30 days. Secondary outcomes included lifestyle changes and health-related quality of life (EQ-5D). Final primary outcome assessment and statistical analyses were blinded. Power calculation required inclusion of 2 × 199 patients. Results: Between March 2024 to May 2025, 43 patients were randomized with 21 to STRONG prehabilitation and 22 to standard care. Around 75% had one risky lifestyle factor, and 25% had ≥ 2; obesity was most common. Shortly after randomization, two prehabilitation participants were excluded due to no surgery. At end-of-intervention, 13/19 in the prehabilitation group had optimized all risky lifestyles versus 0/22 in the control group (p < 0.01). Three additional participants in each group did not undergo surgery. At 30 days, complications occurred in 3/16 prehabilitation and 4/19 control participants (p = 1.00). EQ-5D VAS remained unchanged in the prehabilitation group from baseline but decreased significantly in the control group (p = 0.03). EQ-5D-5L index changes were similar between groups (p = 0.92). Challenges encountered included outsourcing of patients, insufficient recruitment strategy, and a low inclusion rate. Conclusion: The trial was terminated early due to slow recruitment and was therefore not powered to assess the effect of the prehabilitation intervention on postoperative complications. The findings suggest that the STRONG program seems promising for optimizing risky lifestyles, although these lifestyle results should be considered preliminary. Insights from this trial may help address recruitment challenges essential for completing a future adequately powered trial on postoperative complications.
SN - 1932-6203
ER -